Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Response from CEO, CHAI about the Quick Start program in November 2016
Response from CEO, CHAI about the Quick Start program in November 2016
Please click here
December 21, 2016
/
News
Share
the Post
Related
Posts
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
A two pager of what you need to know of Sofosbuvir
New WHO guideline on care and treatment of chronic hepatitis C
Asia Pacific Situational Updates on Generic DAAs – June 2017
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Community group taking actions to enable greater access for generic HCV treatment
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
